Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026, released August 6, 2026.
Guardian Pharmacy Services, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026, released August 6, 2026
- Full financial details contained in Exhibit 99.1, the company’s furnished earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $351.8M, up 2%; residents served rose 8% to approximately 210,000
- Adjusted EBITDA $29.7M versus $25.0M; margin expanded to 8.4% from 7.2%
- Net income $22.1M included an $8.5M payor settlement, limiting earnings quality; adjusted EPS reached $0.29
- FY2026 guidance raised to revenue $1.43B-$1.45B and adjusted EBITDA $129M-$131M
- Wellness Concepts acquisition and Lexington greenfield expand geographic footprint without disclosed acquisition pricing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Guardian Pharmacy Services, Inc. 8-K filings
Get the next GRDN 8-K as it lands
Follow GRDN for push alerts, or ask the research agent what this filing means.